(Q34141234)

31 July 2017

Allelic association of the neuronal nitric oxide synthase (NOS1) gene with schizophrenia (English)

1 reference

31 July 2017

0 references

Shinkai T

1

1 reference

31 July 2017

Ohmori O

series ordinal

2

1 reference

31 July 2017

Hori H

series ordinal

3

1 reference

31 July 2017

Nakamura J

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

31 July 2017

1 reference

31 July 2017

7

1 reference

31 July 2017

560-563

1 reference

31 July 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001041

31 July 2017

0 references

cites work

Nitric oxide in health and disease of the nervous system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Nitric oxide activates guanylate cyclase and increases guanosine 3′:5′-cyclic monophosphate levels in various tissue preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Glutamate, nitric oxide and cell-cell signalling in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Nitric oxide: a radical neurotransmitter in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Impaired antioxidant defense at the onset of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Fatty acid levels in the brains of schizophrenics and normal controls.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Cloning and characterization of inducible nitric oxide synthase from mouse macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Nitric oxide: first in a new class of neurotransmitters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Localization of brain nitric oxide synthase (NOS) to human chromosome 12.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Neuronal NOS: gene structure, mRNA diversity, and functional relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

SNPing away at complex diseases: analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Free radical mechanisms in schizophrenia and tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Free radical pathology in schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Free radical pathology and antioxidant defense in schizophrenia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Reduced level of plasma antioxidant uric acid in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Oxidative injury and potential use of antioxidants in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Effects of haloperidol on antioxidant defense system enzymes in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Lack of phencyclidine-induced effects in mice with reduced neuronal nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Redox aspects of signaling by catecholamines and their metabolites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Oxidative reactions and schizophrenia: a review-discussion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Neuronal NADPH diaphorase is a nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

The brain stem reticular formation in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Mesopontine neurons in schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Distorted distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase neurons in temporal lobe of schizophrenics implies anomalous cortical development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Altered distribution of nicotinamide-adenine dinucleotide phosphate-diaphorase cells in frontal lobe of schizophrenics implies disturbances of cortical development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

Central actions of nitric oxide in regulation of autonomic functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

7 January 2021

Retrograde messengers, long-term potentiation and memory

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

7 January 2021

Enzymes of the antioxidant defense system in chronic schizophrenic patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

7 January 2021

NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

7 January 2021

Manganese superoxide dismutase gene polymorphism and schizophrenia: relation to tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001041

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001041

1 reference

31 July 2017

1 reference